The "XIIIth INTERNATIONAL NIDOVIRUS SYMPOSIUM" was held in Salamanca, Spain, on June 1st--6th, 2014. These symposia are held every three years to assemble scientists from around the world who are doing research on *Nidoviruses*. This large order of enveloped, plus strand RNA viruses consists of many genera and species in the *Coronaviridae*, *Arteriviridae*, and *Roniviridae* families, including many important human and veterinary pathogens, as well as several recently discovered insect viruses in the *Mesoniviridae* family. There are now six human coronaviruses (CoVs) that cause diseases, ranging in severity from generally mild respiratory infections due to HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1, to highly virulent lower respiratory tract infections caused by SARS-CoV and MERS-CoV. SARS-CoV emerged in 2002--2003 and had a fatality rate of around 10%, but close to 50% in patients over 65 years of age. The recently emerging (summer 2012) MERS-CoV has spread to more than 21 countries, with at least 897 laboratory-confirmed cases of human infection reported by WHO, including at least 325 deaths (as for November 3rd 2014).

CoVs are emerging and re-emerging viruses that can mutate to extend their host range, potentially causing devastating pandemics. Human CoVs apparently were zoonotic viruses that adapted to human-to-human transmission. Surveillance of wild life has shown that SARS-CoV and MERS-CoV were likely derived from bats, being civet cats and camels the most likely intermediate hosts for SARS-CoV and MERS-CoV, respectively, which can spread the virus to humans. To determine additional intermediate hosts is a high priority to prevent the continuing rapid spread of MERS-CoV. The rapid development of novel vaccines and antiviral therapies against CoVs that cause acute respiratory syndromes like SARS and MERS is an important priority for governments and public health agencies worldwide. Similarly, animal CoVs such as a highly virulent porcine epidemic diarrhea virus (PEDV) have reemerged in China in 2010 and soon later (2013) in the United States, affecting 31 states and causing a 10% loss of newborn pigs, now extending to Canada and Mexico. In addition, a previously unknown porcine delta CoV (SDCoV), causing lesions similar to those produced by genetically distinct TGEV and PEDV, was confirmed in China in 2012, and in the States in 2014 affecting 17 states with an average of 7% of the pig population seropositive.

In order to generate a key publication that brings together most of the information discussed during the XIIIth Nidovirus Symposium, we decided to assemble two Special Issues on Nidoviruses, to disseminate among scientists from around the world the updated information on MERS-CoV and other Nidoviruses concerning their molecular biology, virus entrance, pathogenesis, determinants of virulence, mechanisms of transmission and epidemiology, phylogeny, host range, diagnosis, strategies for prevention, and development of vaccines and antiviral therapies. Previous Nidovirus Symposia led to international collaborations that have been very important in expediting research on newly emerging and re-emerging Nidoviruses.

The first Special Issue on Nidoviruses has already been completed and will be followed very soon by Nidoviruses II. In the first volume, 18 chapters have been included. In these chapters an overview of the state of the art in the Nidovirus field is being offered to the reader. These chapters have been organized in five sections. In the first one, *virus entry and assembly* are addressed. In one chapter a structural view of coronavirus receptor interactions is presented (J.M. Casasnovas), followed by chapters on the envelope proteins of arterivirus (M. Veit) and the spike protein of avian coronavirus (M.H. Verheije). The second main topic of the special issue addresses *viral genome expression and genome replication*. This theme is covered by four chapters, including a comprehensive review of the CoV replicase structure (B. Newman), the development of reverse genetic systems, both replicons and infectious cDNAs (F. Almazan), the analysis of alphacoronavirus terminal genome regions (J. Ziebuhr), and insights into RNA synthesis, capping, and proofreading mechanism of SARS-CoV (I. Imbert). The third topic, *virus-host interaction and pathogenesis*, was covered by a comprehensive review on the porcine respiratory and reproductive syndrome virus (PRRSV), a member of the *Arteriviridiae* family. These chapters addressed the modulation of innate immunity signaling (D. Yoo), and the effect of phosphatidylinositol-3-kinase (P13K) in PRRSV infected cells (A. N. Zakhartchouk). CoV-induced stress responses were also reviewed (D. X. Liu). In addition, the molecular basis of CoV virulence using the SARS-CoV system (L. Enjuanes) or HCoV-OC43 (P. Talbot) were addressed. A forth subject in the section of *epidemiology, evolution and emerging viruses* has been documented in three chapters. Two of them focused on PRRSV as a model and analyzed virus evolution by recombination (M. Drigo), or using next generation sequencing technologies (T. Ait-Ali). In addition a critical review on serological assays for emerging coronaviruses is presented (M.A. Müller). The last section on *disease control strategies* includes three chapters, one on nidovirus papain-like proteases mechanism of action and inhibitors (S. C. Baker), another one on MERS-CoV entry inhibitors (S. Jiang) and a study on CoV non-structural protein 16, addressing evasion, attenuation and possible treatments (R.S. Baric).

We certainly hope that you will find the content of this Nidoviruses I special issue, and the next one to come, informative and scientifically rewarding, and that they will provide you updated information on Nidoviruses.
